Global Financial Private Client’s Invesco NASDAQ 100 ETF QQQM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.37M Sell
7,807
-207
-3% -$58.6K 0.64% 41
2026
Q1
$1.9M Buy
8,014
+304
+4% +$76K 0.62% 43
2025
Q4
$1.95M Sell
7,710
-84
-1% -$21.2K 0.68% 37
2025
Q3
$1.93M Buy
7,794
+2,211
+40% +$521K 0.69% 42
2025
Q2
$1.27M Buy
5,583
+162
+3% +$33.2K 0.48% 57
2025
Q1
$1.05M Sell
5,421
-1,776
-25% -$372K 0.4% 68
2024
Q4
$1.51M Buy
7,197
+1,976
+38% +$411K 0.57% 46
2024
Q3
$1.05M Sell
5,221
-2,409
-32% -$469K 0.41% 66
2024
Q2
$1.5M Buy
7,630
+2,620
+52% +$485K 0.63% 40
2024
Q1
$917K Buy
5,010
+286
+6% +$50.5K 0.39% 69
2023
Q4
$796K Buy
4,724
+174
+4% +$27.2K 0.37% 76
2023
Q3
$676K Buy
4,550
+1,305
+40% +$199K 0.35% 74
2023
Q2
$494K Buy
+3,245
New +$449K 0.24% 98
2022
Q1
Sell
-31
Closed -$5.07K 673
2021
Q4
$5.07K Buy
+31
New +$4.92K ﹤0.01% 452

Other funds holding QQQM

Global Financial Private Client's QQQM Position: Q2 2026 in Review

Global Financial Private Client reduced its Invesco NASDAQ 100 ETF (QQQM) stake by 2.6% in Q2 2026, selling an estimated $58.6K and leaving 7,807 shares worth $2.37M. The position accounts for 0.64% of the portfolio, ranked #41.

Global Financial Private Client first reported a position in QQQM in Q4 2021 and has held it in 14 quarters since. 1,353 funds tracked by Wall St. Rank hold QQQM as of Q2 2026.

  • Global Financial Private Client held 7,807 shares of Invesco NASDAQ 100 ETF worth $2.37M as of Q2 2026.
  • Global Financial Private Client sold 207 Invesco NASDAQ 100 ETF shares in Q2 2026, an estimated $58.6K.
  • Invesco NASDAQ 100 ETF made up 0.64% of Global Financial Private Client's portfolio in Q2 2026, its #41 holding.
  • Global Financial Private Client first reported a position in Invesco NASDAQ 100 ETF in Q4 2021 and has held it in 14 quarters since.
  • 1,353 funds tracked by Wall St. Rank held Invesco NASDAQ 100 ETF as of Q2 2026.

Based on Global Financial Private Client's 13F filing for Q2 2026, filed 20 Jul 2026.